Illumina, Inc. Price Today
Illumina, Inc.
ILMN
Healthcare
$29.67B
💰
Market Cap
0
💸
Price to Earnings
$-28.8
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
8 |
Strong Buy |
5 |
Hold |
11 |
Sell |
2 |
Strong Sell |
1 |
ILMN Price Forecast Target
187.7 👉 328.0 +75%
ILMN EPS Forecast
-28.8 👉 3.1 +-111%
Financials
Profit Margin
-101 %
Revenue Growth
-11.1 %
Dividend
$ 0
Held Percent
0.3% - Insiders
93.5% - Institutions
6.2% - Public
Major Fund Holders
-
💰 Baillie Gifford and Company $2.6B
-
💰 Vanguard Group Inc $3.1B
-
💰 Blackrock Inc. $2.9B
-
💰 State Street Corporation $1.5B
-
💰 Edgewood Management Llc $1.3B
Stock Ideas
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Stephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at r…📮FAQ
Some Frequently Asked Questions.
The Illumina, Inc. industry is Diagnostics & Research
The Illumina, Inc. sector is Healthcare
The Illumina, Inc. forecasted predicted Price to Earnings PE ratio is 59.8
The Illumina, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Illumina, Inc. is $29.67B
There are total of 157744275 float shares with 93.5% held by Institutions and 0.3% held by insiders
The MIllumina, Inc. forecasted Earnings per Share EPS is $3.1
The Illumina, Inc. Earnings per Share EPS is -28.8
The Illumina, Inc. company has $3145000000 gross profits with -101 profit margins
The Illumina, Inc. Earnings Growth is -0.965% with -0.965% quarterly earnings growth
The Illumina, Inc. Revenue is $4448000000 with -0.111 revenue growth
The price target for Illumina, Inc. stock is $328.0 for the high target and $140.0 for the low target
The consensus analyst recommendations for Illumina, Inc. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Illumina, Inc. is Hold, with the following breakdown:
- Buy: 8
- Strong Buy: 5
- Hold: 11
- Sell: 2
- Strong Sell: 1
The Beta of Illumina, Inc. is 1.1
The dividend of Illumina, Inc. is $0
The dividend yield of Illumina, Inc. is 0%
The biggest institutional and mutual fund holders of Illumina, Inc. stock are
- Baillie Gifford and Company
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
The Illumina, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0